Temozolomide, an oral alkylating agent, is a commonly used medicine in the treatment of anaplastic astrocytoma and glioblastoma multiforme. This paper will present the mechanism of action as well as the clinical role for this chemotherapeutic drug.
No takes yet. Share an insight, caveat, or question.
Wesolowski et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: